Cargando…
The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan
Heart failure (HF) is one of the leading causes of morbidity, mortality, and health care expenditures in the US and worldwide. For three decades, the pillars of treatment of HF with reduced ejection fraction (HFrEF) were medications that targeted the sympathetic nervous system (SNS) and the renin-an...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575222/ https://www.ncbi.nlm.nih.gov/pubmed/28883863 http://dx.doi.org/10.5114/aoms.2017.68813 |